Jacques P. Barbet

1 Rue Aronnax, CS 10112
Rouez, 44817, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

"Tumor Targeting, Imaging, RadiotherapieS" 17th edition of the workshop organized by the Cancéropôle Grand-Ouest, October 9-12, 2024, Erquy, France

"Tumor Targeting, Imaging, RadiotherapieS" 17th edition of the workshop organized by the Cancéropôle Grand-Ouest, October 9-12, 2024, Erquy, France

Journal: Bulletin du cancer

Published: December 10, 2025

Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis.

Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis.

Journal: The Journal of antimicrobial chemotherapy

Published: July 29, 2025

"Optimizing Imaging and Dose-Response in Radiotherapies" XVIth workshop organised by the Cancéropôle Grand-Ouest's "Vectorisation, Imagerie, Radiothérapies" network - 4-7 October 2023, Erquy, France

"Optimizing Imaging and Dose-Response in Radiotherapies" XVIth workshop organised by the Cancéropôle Grand-Ouest's "Vectorisation, Imagerie, Radiothérapies" network - 4-7 October 2023, Erquy, France

Journal: Bulletin du cancer

Published: September 18, 2024

"New Modalities in Cancer Imaging and Therapy" XVth edition of the workshop organized by the network "Tumor Targeting, Imaging, Radiotherapies" of the Cancéropôle Grand-Ouest, 5-8 October 2022, France

"New Modalities in Cancer Imaging and Therapy" XVth edition of the workshop organized by the network "Tumor Targeting, Imaging, Radiotherapies" of the Cancéropôle Grand-Ouest, 5-8 October 2022, France

Journal: Bulletin du cancer

Published: January 23, 2023

Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.

Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.

Journal: Cancers

Published: September 24, 2021

Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model.

Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model.

Journal: Pharmaceutics

Published: December 04, 2020

Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.

Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 08, 2020

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 24, 2020

Editorial: Nuclear Medicine in the Context of Personalized Medicine.

Editorial: Nuclear Medicine in the Context of Personalized Medicine.

Journal: Frontiers in medicine

Published: March 27, 2020

Radioimmunotherapy: the reasons for confidential clinical use and hope for development

Radioimmunotherapy: the reasons for confidential clinical use and hope for development

Journal: Medecine sciences : M/S

Published: January 07, 2020

Death of an apprentice bodybuilder following 2,4-dinitrophenol and clenbuterol intake.

Death of an apprentice bodybuilder following 2,4-dinitrophenol and clenbuterol intake.

Journal: International journal of legal medicine

Published: October 18, 2019

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 06, 2019

Showing 1-12 of 62

Last Updated: 09/26/2026